Core Programme Clusters

Communicable Diseases and Disease Surveillance

Tuberculosis

 

United States, WHO, and the Government of India:

Partners in confronting tuberculosis

 

Mr. David C. Mulford, United States Ambassador to India;

Dr S. J. Habayeb, WHO Representative to India; and

Dr L. S. Chauhan, Deputy Director General (TB), Ministry of Health and Family Welfare, Government of India

On 26 September 2006, Mr David C. Mulford, US Ambassador to India, and Dr S. J. Habayeb, WHO Representative to India, signed a Joint Statement on their strong commitment to TB control.  The US Government is providing, through the US Agency for International Development (USAID), an amount of US$4.2 million to WHO for technical support to the Revised National Tuberculosis Control Programme of the Government of India in 2006.  The signing event was undertaken in the presence of Dr L. S. Chauhan, Deputy Director General, Ministry of Health and Family Welfare, Government of India; George Deikun, Mission Director, USAID; Robert Clay, Director, Office of Population, Health and Nutrition, USAID;  other US officials, including Larry Schwartz, Christopher Barrett, Don Brown, Kris Easter, and Corina Sanders; and WHO officials: Dr Suvanand Sahu and Dr D. Fraser Wares.

Dr Habayeb commended the strength of the technical collaboration with the US in the health sector, through USAID, CDC, and HHS in support of health development efforts in India.  In addition to TB control, he noted that cooperation covers key joint priority areas for both the US and WHO, such as disease surveillance, malaria control, polio eradication and influenza pandemic preparedness & response.  The development assistance of USAID to WHO-India has aggregated at US $56 million in recent years.  The US support has been instrumental in bringing much value added to the health programmes, notably by supporting research, sharing international experience, promoting quality aspects, facilitating state level implementation, and dealing with second generation issues, such as drug resistance and HIV/TB interaction.   Ultimately, and above all, this generous support saves lives, and the benefits accrue to the poor, since the disease impact disproportionately affects poor households.

Finally, the WHO Representative applauded the major progress made by the National TB Control Programme of the Government of India, which has now attained universal coverage, promoted public private partnerships, and embarked on further quality improvements, while dealing with 2nd generation issues and promoting sustainability.

 

 

 

 

| | | | | |